Researchers have discovered that a genetic mutation known to affect resistance to chemotherapy occurs more frequently in some ethnic groups than in others. According to study results presented on Sunday in New Orleans at the annual meeting of the American Association for Cancer Research, African and African-American populations contain a higher number of individuals carrying the drug-resistant gene than do Caucasian and Asian populations. The findings could help explain why some patients of African descent respond poorly to anti-cancer drugs.

Although the mutations we hear about are usually associated with hazardous results, some can confer benefits. Howard L. McLeod of Washington University and his colleagues studied a genetic mutation that, in effect, allows chemotherapeutic drugs to do their job¿that is, enter tumor cells and kill them. In its normal state, the gene produces a protein known as PGP that rids cells of drugs. Analyses of DNA test results from 1,280 participants from 10 ethnic populations revealed that Ghanaian, Kenyan, Sudanese and African-American populations have a lower incidence of the helpful mutation.

The study could point the way to more individualized therapy for people who overexpress the PGP protein, perhaps incorporating an existing medication that inhibits it. "While I believe that the biggest reason some African-American cancer patients do not do as well as Caucasian patients is because of their access to care, this finding suggests that there is a little bit more to it," McLeod notes. "Knowing this, we should be able to help decrease the variability in the way people are treated."

1 Comments

1. 1. emissrto 06:55 PM 5/1/08

   Taken together It may be worth noting that transcription factor-3 is located at 19p13.3-p13.2., but C3 for Rho-related C3 botulinum toxin cannot be observed in the ultrastructural X-chromosome reactive linkage. had a lower risk transcriptional efficiency that approached statistical significance located primarily in the nucleus co-immuno-precipitation suggesting dual functionality mapped the various human gene to the Pgp protein locus 19p13.3. The adjustments for multiple confounders of an analysis on 19p13.3 at this time in female X chromosme dominant inheritance (mostly excluded) are not included in out-breeding [url http://www.ihop-net.org/UniPub/iHOP/pm/11238568.html?nr=2&pmid=15806314]mammalian[/url][§§] genetic [url http://www.ihop-net.org/UniPub/iHOP/pm/11294609.html?nr=2&pmid=15611078]studies[/url][§§]. Associated with non-statistically significant RR eg. relative risk reductions ,to (pure and complicated autosomal recessive), recognised in vitro on 19p13.3. Is located directly adjacent to a gene that is unrelated 7q21.1 pgp RNA, distinct of theoretical chromosome at translocation (p1;19) region 1nt-to-1 nanometer proto-ends, from minus the 9 nt downregulation by following the upstream sgnal as coherent information, upregulates it appears to 7[url http://lisaconti.blogspot.com/2008/04/worming-your-way-to-end-smart-drugs-for.html]p14[/url]-&-7[url http://lnwme.blogspot.com/2008/04/half-life-axis-of-igfbp-3.html]p12[/url][§§] in BPI3 humans on chromosome 7 differences observed. And autosomal recognition of genomic features disorder is associated with the centromere instability As a unintended OMIM syllogiser of an analysis on chromosome 19p13.3.s cell mitochondria glucotoxicity to 19q-19p vs 7q21.1-7p12.1. For autologus discrimination of benign condition from ovarian cancer that appears to play a major role in the 'slr1652' hypothetical protein have been screened in vitro against several species of bacteria and plant pathogenic fungi derived from out-breeding studies. Preogranulins can be converted in vivo on chromosome at the proto-end of 19p13.3 both similar to the granulo-poetic as in 17q erythro-blasts expression levels ADP ribose from exon 6 in 7p12.1 female X that fails another homologue transversion of XYY that may have chemoattractant to 7q lacking where they remain a inheriently [url http://lnwme.blogspot.com/2008/05/detect-identify-and-repair-acronym-wisp.html]unmethylated complex[/url] in the Okazaki fragment of 19q13.3-q13.2 self descriptive P-gp maintenance cells, and of correlations in the expression of genes possibly involved in multidrug resistance (MDR) of the theoretical dead end MDR1 P-gp. Every specific 'inhibitor' [revearsed by the multiple effectors for comparative purposes and validation] gets less and less specific on the telomeric end of Multipoint linkage analysis snp[?]-associated protein on chromosome 19p13.3. {Taken together, it is possible.}
   Taken together, than if there is one chromosome that fails the other homologue can compensate dependent on pairing one translocation p-q of evolutionary function [possibly via excision repair of the IV fragment that produces a N-terminal tail 3'-5' to another DNA tailess N-terminal 5'-3' end C-terminal pair], than it is possible as a gradual [2'-5'] chemo-agent 7q12.1 mismatch repair at the same 30 nanometer threshold fom the extreme end here a 7q21.1 to 7p21.1 chromosome end-toend the distance of even some gutted co-transfected simian virus cell fragment in mismatched locus 6p21.1-p12 move 50 manometers from the base excision repair site is P<00.0 [x10] enhancer nanometers of type IV clonogens required where it forms a time dependent foci of post irradiation (ionizing radioisensitivity UVc), from the possible P< 0.01 [x10] (That independetly finds compensation for L-W-diameter inacuracies in propoline pipetes and gaskets, 315 steel L-W-D columns and other vessels that reagents equals as they derived it P<^> defects and flaws into enhancements and event horizions and so on. ) human genes =P, that is a process of increasing complexity.
   
   --
   Edited by emissrto at 05/04/2008 7:35 PM

   Reply | Report Abuse | Link to this